SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001346302-20-000049
Filing Date
2020-08-10
Accepted
2020-08-10 16:37:28
Documents
64
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xers-20200630.htm   iXBRL 10-Q 2220148
2 EX-10.1 exh101secondamendmentt.htm EX-10.1 203414
3 EX-10.2 exh102firstamendmentto.htm EX-10.2 57185
4 EX-31.1 q22020exhibit311.htm EX-31.1 13544
5 EX-31.2 q22020exhibit312.htm EX-31.2 13555
6 EX-32.1 q22020exhibit321.htm EX-32.1 10200
  Complete submission text file 0001346302-20-000049.txt   7685339

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xers-20200630.xsd EX-101.SCH 42466
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xers-20200630_cal.xml EX-101.CAL 39255
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xers-20200630_def.xml EX-101.DEF 262075
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xers-20200630_lab.xml EX-101.LAB 539797
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xers-20200630_pre.xml EX-101.PRE 355937
12 EXTRACTED XBRL INSTANCE DOCUMENT xers-20200630_htm.xml XML 1132908
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38536 | Film No.: 201089909
SIC: 2834 Pharmaceutical Preparations